Serum xanthine oxidase in breast carcinoma.
This study comprises 46 patients with various stages of breast carcinoma and 49 normal women as control group. Serum xanthine oxidase and uric acid levels were determined. Assessment in terms of changes of the enzyme xanthine oxidase was carried out prior and after surgery as a short term follow up. There was a significant fall of serum xanthine oxidase in patients with breast carcinoma. The level of serum xanthine oxidase was found to be varied with the stage of cancer.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000201:enzymology* / Q000601:surgery; D005260:Female; D006801:Humans; D008875:Middle Aged; D009243:NAD / Q000378:metabolism; D009367:Neoplasm Staging; D013997:Time Factors; D014527:Uric Acid / Q000097:blood; D014969:Xanthine Oxidase / Q000097:blood* / Q000378:metabolism; D014970:Xanthines / Q000378:metabolism
D014970:Xanthines; D009243:NAD; D014527:Uric Acid; D014969:Xanthine Oxidase